Trial Profile
A phase II study of systemic therapy with CPT-11 (Camptosar HCl) and cisplatin in patients with advanced gastric cancer to be followed by surgical resection and postoperative intraperitoneal chemotherapy
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2006
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Irinotecan (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 14 Feb 2006 New trial record.